Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Heartbeat Trust is an Irish non-profit organization dedicated to the prevention and management of heart failure. Founded by specialists from St. Vincent's University Hospital, the Trust developed the landmark STOP-HF (Screening To Prevent Heart Failure) program, which utilizes natriuretic peptide biomarkers to identify at-risk patients. The organization provides specialized clinical services, patient support, and conducts extensive cardiovascular research to improve outcomes for those with heart disease. It has been instrumental in establishing heart failure clinics and virtual consultation services across Ireland to bridge the gap between primary and specialist care. In 2022, the Trust merged with Croí, the Heart & Stroke Charity, to consolidate cardiac support services and expand their national reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Heartbeat Trust.